Chitosan as a potential drug nanocarrier for oral disease treatment

Mohd Zayi, Nora Azirah and Mohamad, Mohd Yusof and Harun @ Ismail, Ahmad Fahmi and Mohamed Halim, Muhammad Lutfi and Arzmi, Mohd Hafiz (2020) Chitosan as a potential drug nanocarrier for oral disease treatment. In: 3rd International Conference on Oral Microbiology and Oral Immunology in conjunction with 13th Postgraduate e-Conference 2020, 8th-9th September 2020, Kuala Lumpur (Online via Google Meet). (Unpublished)

	PDF (Poster) - Presentation Restricted to Registered users only Download (450kB) | Request a copy
	PDF (Program and abstract) Restricted to Registered users only Download (364kB) | Request a copy

Abstract

Oral drug delivery is widely used in the treatment of oral disease. Due to the complexity of the gastrointestinal system, local drug delivery offers a more targeted and attractive alternative to systemic delivery. Recently, nanotechnology has drawn prominent interest in the topical application which can maintain the drug concentrations on the target site. Chitosan (CS) is a natural biodegradable polymer that is commonly used for drug encapsulation. It has a longer half-life and greater drug entrapment efficiency. The size of particle and stability colloidal dispersions are the most critical part in nano-drug delivery. This study aims to determine the effect of chitosan concentration on particle size, polydispersity index (PDI) and zeta potential. The CS nanoparticle was prepared by ionic crosslinking using tripolyphosphate (TPP) in the ratio of 20 CS: 100 TPP. Aqueous TPP was added dropwise into different concentration of CS (1 to 3 mg/mL in acetic acid) under vigorous stirring at room temperature. The mean size, PDI and zeta potential of nanoparticle were measured using dynamic light scattering. Our findings showed that the increase of chitosan concentration at a constant concentration of TPP increased the size of nanoparticles. Furthermore, the particles that were prepared under 1% w/v CS concentration, 1% w/v TPP concentration, and stirring speed at 6000 rpm had the smallest diameter of 198.2±18.62nm. In addition, different concentrations of chitosan exhibited narrow particle size distribution with PDI values approximately 0.4 and zeta potential ranging from 62-69 mV. In conclusion, nanoparticle size can be controlled by adjusting chitosan concentration which can be used in the encapsulation of nanotherapeutic drug. This offers a promising candidate for nanodrug carrier.

Item Type:	Conference or Workshop Item (Poster)
Additional Information:	8264/83845
Uncontrolled Keywords:	Chitosan, drug, nanocarrier
Subjects:	R Medicine > RK Dentistry > RK318 Oral and Dental Medicine. Pathology. Diseases-Therapeutics-General Works
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Allied Health Sciences Kulliyyah of Dentistry
Depositing User:	Dr Mohd Yusof Mohamad
Date Deposited:	28 Oct 2020 12:40
Last Modified:	28 Oct 2020 12:41
URI:	http://irep.iium.edu.my/id/eprint/83845

Actions (login required)

View Item